Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Freytag

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Fortschritte Der Medizin|September 10, 1989
[Treatment of acne with a yeast preparation]G Weber, A Adamczyk, S Freytag
Molecular Pharmacology|September 1, 1988
Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzymeS Lenzen, S Freytag, U Panten
Pharmacopsychiatry|January 1, 1994
Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT)E Rüther, R Ritter, M Apecechea, et al.
Progress in Clinical and Biological Research|January 1, 1982
Reversible inhibitors of aldehyde dehydrogenaseH Weiner, S Freytag, J M Fox, et al.
Deutsche Medizinische Wochenschrift (1946)|February 24, 2001
[Australian Refined Diagnosis Related Groups. Formal and inherent problems of grouping with the example of stroke care]C Kugler, S Freytag, R Stillger, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) geneM Gabel, J H Kim, A Kolozsvary, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 20, 2005
[Allocating and scheduling operating room time]S Freytag, F Dexter, R H Epstein, et al.
Pharmacology & Toxicology|March 1, 1990
Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cellsS Lenzen, S Freytag, U Panten, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2000
Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapyE Rüther, R Ritter, M Apecechea, et al.
Cephalalgia : an International Journal of Headache|April 12, 2001
Cyclandelate in the prophylaxis of migraine: a placebo-controlled studyH C Diener, P Krupp, T Schmitt, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Fortschritte Der Medizin|September 10, 1989
[Treatment of acne with a yeast preparation]G Weber, A Adamczyk, S Freytag
Molecular Pharmacology|September 1, 1988
Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzymeS Lenzen, S Freytag, U Panten
Pharmacopsychiatry|January 1, 1994
Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT)E Rüther, R Ritter, M Apecechea, et al.
Progress in Clinical and Biological Research|January 1, 1982
Reversible inhibitors of aldehyde dehydrogenaseH Weiner, S Freytag, J M Fox, et al.
Deutsche Medizinische Wochenschrift (1946)|February 24, 2001
[Australian Refined Diagnosis Related Groups. Formal and inherent problems of grouping with the example of stroke care]C Kugler, S Freytag, R Stillger, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) geneM Gabel, J H Kim, A Kolozsvary, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 20, 2005
[Allocating and scheduling operating room time]S Freytag, F Dexter, R H Epstein, et al.
Pharmacology & Toxicology|March 1, 1990
Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cellsS Lenzen, S Freytag, U Panten, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2000
Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapyE Rüther, R Ritter, M Apecechea, et al.
Cephalalgia : an International Journal of Headache|April 12, 2001
Cyclandelate in the prophylaxis of migraine: a placebo-controlled studyH C Diener, P Krupp, T Schmitt, et al.
Pageof 2